Skip to main content
S 2126 113th Congress Senate Health Congressional oversight Department of Health and Human Services Executive agency funding and structure Health programs administration and funding Health technology, devices, supplies Long-term, rehabilitative, and terminal care Medical research Product development and innovation Research administration and funding Surgery and anesthesia

Regenerative Medicine Promotion Act of 2014

Introduced: March 13, 2014 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 13, 2014
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 13, 2014
Introduced in Senate
 Plain-English summary Congressional Research Service

Regenerative Medicine Promotion Act of 2014 - Requires the Comptroller General to submit to Congress a report identifying all ongoing federal programs and activities regarding regenerative medicine.

Directs the Secretary of Health and Human Services (HHS) to establish a Regenerative Medicine Coordinating Council, which shall:

  • prepare a national strategy to support research into regenerative medicine and enable the development of drugs, biological products, medical devices, and biomaterials for use in regenerative medicine;
  • develop national goals for regenerative medicine research and product development;
  • prepare a plan specifying priorities for research into regenerative medicine;
  • identify sources of funding for research into regenerative medicine and areas where such funding is inadequate or duplicative;
  • make recommendations regarding federal policies to support development and marketing of regenerative medicine products;
  • develop consensus standards regarding scientific issues critical to regulator approval of regenerative medicine products; and
  • determine the need for establishing centers of excellence or consortia to further advance regenerative medicine.

Directs the Council to: (1) adopt procedures to ensure the receipt of public input; and (2) submit an annual report on its activities to Congress, the Director of the National Institutes of Health (NIH), and the Commissioner of Food and Drugs (FDA).

What's happening now March 13, 2014

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2